[ad_1]
Federal Chancellor Kurz demands speed from the EU Medicines Agency and receives support from Berlin. The EMA, however, does not want to get carried away by politics.
Impatience grows in European capitals. In many places, the understanding of the vaccine shortage has turned to anger at the beginning of the year by the (supposedly) tough bureaucracy of the EU approval authority EMA (European Medicines Agency). Background: AstraZeneca’s product, for which the EU Commission has secured an option for 300 million doses, is still in the approval phase. For Chancellor Sebastian Kurz and some of his European counterparts – from Denmark, the Czech Republic and Greece – completely incomprehensible. And reason enough to make the demand for “efficient and non-bureaucratic” approval of the vaccine a big topic at Thursday night’s video summit. “AstraZeneca can provide two million doses of vaccines for Austria in the first trimester,” says Kurz. “Count every week to save lives and jobs. Europe must not be left behind here. “
